Cited by 17,038Global Cancer Incidence and ScreeningColorectal Cancer Screening and DetectionEconomic and Financial Impacts of Cancer

The DOI matches its Crossref record; 83 of the 85 references it cites were found in a registry or an index.

Cancer statistics in China, 2015

Open access

Chen, Wanqing, Zheng, Rongshou, Baade, Peter D., Zhang, Siwei, Zeng, Hongmei, Bray, Freddie, Jemal, Ahmedin, Yu, Xue Qin, He, Jie·2016·CA: A Cancer Journal for Clinicians

DOI 10.3322/caac.21338

Open this paper in CoChat — free account Open PDF

Abstract

With increasing incidence and mortality, cancer is the leading cause of death in China and is a major public health problem. Because of China's massive population (1.37 billion), previous national incidence and mortality estimates have been limited to small samples of the population using data from the 1990s or based on a specific year. With high‐quality data from an additional number of population‐based registries now available through the National Central Cancer Registry of China, the authors analyzed data from 72 local, population‐based cancer registries (2009‐2011), representing 6.5% of the population, to estimate the number of new cases and cancer deaths for 2015. Data from 22 registries were used for trend analyses (2000‐2011). The results indicated that an estimated 4292,000 new cancer cases and 2814,000 cancer deaths would occur in China in 2015, with lung cancer being the most common incident cancer and the leading cause of cancer death. Stomach, esophageal, and liver cancers were also commonly diagnosed and were identified as leading causes of cancer death. Residents of rural areas had significantly higher age‐standardized (Segi population) incidence and mortality rates for all cancers combined than urban residents (213.6 per 100,000 vs 191.5 per 100,000 for incidence; 149.0 per 100,000 vs 109.5 per 100,000 for mortality, respectively). For all cancers combined, the incidence rates were stable during 2000 through 2011 for males (+0.2% per year; P = .1), whereas they increased significantly (+2.2% per year; P < .05) among females. In contrast, the mortality rates since 2006 have decreased significantly for both males (−1.4% per year; P < .05) and females (−1.1% per year; P < .05). Many of the estimated cancer cases and deaths can be prevented through reducing the prevalence of risk factors, while increasing the effectiveness of clinical care delivery, particularly for those living in rural areas and in disadvantaged populations. CA Cancer J Clin 2016;66:115–132. © 2016 American Cancer Society.

Integrity signals

Registry

Crossref · 10.3322/caac.21338

Cites

83 of 83 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Global cancer statistics
Jemal, A., Bray, F., Ferlay, J., Ward, E., & Forman, D. (2011) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 55,077
Self-citation
Global cancer statistics, 2012
Torre, L. A., Bray, F., Siegel, R. L., Ferlay, J., Lortet‐Tieulent, J., & Jemal, A. (2015) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21262 · Cited by 27,235
Self-citation
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Ferlay, J., Shin, H., Bray, F., Forman, D., Mathers, C. D., & Parkin, D. M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25516 · Cited by 21,468
Self-citation
China statistical yearbook
中華人民共和国国家統計局 (1988) · Medical Entomology and Zoology · Cited by 12,443
Cancer statistics, 2015
Siegel, R. L., Miller, K. D., & Jemal, A. (2015) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21254 · Cited by 11,854
Self-citation
SEER Cancer Statistics Review, 1975-2003
Ries, L. A. G., Harkins, D., Krapcho, M. F., Mariotto, A. B., Miller, B., Feuer, E. J., Clegg, L. X., Eisner, M. P., Horner, M., Howlader, N., et al. (2006) · Digital Archive @ GSU · Cited by 11,404
Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
The National Lung Screening Trial Research Team (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1102873 · Cited by 11,064
Cancer Incidence in Five Continents
Doll, R., Muir, C. S., & Waterhouse, J. A. H. (1970) · Springer eBooks · doi:10.1007/978-3-642-85851-2 · Cited by 8,485
Cancer Incidence in Five Continents
(1966) · doi:10.1007/978-3-642-85849-9 · Cited by 5,936
The Health consequences of smoking—50 years of progress : a report of the Surgeon General
Lushniak, B. D., Samet, J. M., Pechacek, T. F., Norman, L., & Taylor, P. A. (2014) · Cited by 4,990

Show all 85 references

Research works printed but not linked: 5

National Cancer Center, Disease Prevention and Control Bureau, Ministry of Health, 2012, Chinese Cancer Registry Annual Report 2012
Ferlay J, 2005, Check and Conversion Programs for Cancer Registries (IARC/IACR Tools for Cancer Registries). IARC Technical Report No. 42
Chen Z, 2008, National Death Survey Report 2004–2005
2015, Will China make the great leap in tobacco control in 2015 [editorial]?, Lancet., 385, 2122
Kang LN, 2014, Cancer screening and prevention in China [serial online], Cancer Control 2014., 131

Sorted by citations

Items 601–700 of 1,032

Chemopreventive effects of some popular phytochemicals on human colon cancer: a review
Zhao, Y., Hu, X., Zuo, X., & Wang, M. (2018) · Food & Function · doi:10.1039/c8fo00850g · Cited by 104
Prognostic value of prognostic nutritional index in lung cancer: a meta-analysis
Li, D., Yuan, X., Liu, J., Li, C., & Li, W. (2018) · Journal of Thoracic Disease · doi:10.21037/jtd.2018.08.51 · Cited by 104
The short-term effects of air pollution on respiratory diseases and lung cancer mortality in Hefei: A time-series analysis
Zhu, F., Ding, R., Lei, R., Cheng, H., Liu, J., Shen, C., Zhang, C., Xu, Y., Xiao, C., Li, X., et al. (2018) · Respiratory Medicine · doi:10.1016/j.rmed.2018.11.019 · Cited by 104
miR-142-5p enhances cisplatin-induced apoptosis in ovarian cancer cells by targeting multiple anti-apoptotic genes
Li, X., Chen, W., Jin, Y., Xue, R., Su, J., Mu, Z., Li, J., & Jiang, S. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.01.009 · Cited by 105
Self-citation
Salivary Microbial Dysbiosis is Associated with Systemic Inflammatory Markers and Predicted Oral Metabolites in Non-Small Cell Lung Cancer Patients
Zhang, W., Luo, J., Dong, X., Zhao, S., Hao, Y., Peng, C., Shi, H., Zhou, Y., Shan, L., Sun, Q., et al. (2019) · Journal of Cancer · doi:10.7150/jca.28077 · Cited by 104
Health, income and poverty: evidence from China’s rural household survey
Zhou, Y., Guo, Y., & Liu, Y. (2020) · International Journal for Equity in Health · doi:10.1186/s12939-020-1121-0 · Cited by 111
Targeting angiogenesis for liver cancer: Past, present, and future
Zhu, X., Tang, Z., & Sun, H. (2020) · Genes & Diseases · doi:10.1016/j.gendis.2020.03.010 · Cited by 105
The Landscape of Immune Cells Infiltrating in Prostate Cancer
Wu, Z., Chen, H., Luo, W., Zhang, H., Li, G., Zeng, F., & Deng, F. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.517637 · Cited by 109
Recent progress in circular RNAs in human cancers
Huang, G., Li, S., Yang, N., Zou, Y., Zheng, D., & Xiao, T. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.07.002 · Cited by 103
Myricetin suppresses breast cancer metastasis through down‐regulating the activity of matrix metalloproteinase (MMP)‐2/9
Ci, Y., Zhang, Y., Liu, Y., Lu, S., Cao, J., Li, H., Zhang, J., Huang, Z., Zhu, X., Gao, J., et al. (2018) · Phytotherapy Research · doi:10.1002/ptr.6071 · Cited by 103
Traditional Chinese medicine-combination therapies utilizing nanotechnology-based targeted delivery systems: a new strategy for antitumor treatment
Ma, Z., Fan, Y., Wu, Y., Kebebe, D., Zhang, B., Lü, P., Pi, J., & Liu, Z. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s197889 · Cited by 110
Gut microbiota shifts in patients with gastric cancer in perioperative period
Liang, W., Yang, Y., Wang, H., Wang, H., Yu, X., Lu, Y., Shen, S., & Teng, L. (2019) · Medicine · doi:10.1097/md.0000000000016626 · Cited by 105
Self-citation
Quercetin Enhanced Paclitaxel Therapeutic Effects Towards PC-3 Prostate Cancer Through ER Stress Induction and ROS Production
Zhang, X., Huang, J., Yu, C., Xiang, L., Li, L., Shi, D., & Lin, F. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s228453 · Cited by 103
Anti-Tumor Drug Discovery Based on Natural Product β-Elemene: Anti-Tumor Mechanisms and Structural Modification
Bai, Z., Yao, C., Zhu, J., Xie, Y., Ye, X., Bai, R., & Xie, T. (2021) · Molecules · doi:10.3390/molecules26061499 · Cited by 105
Prostate cancer treatment – China's perspective
Liu, J., Dong, L., Zhu, Y., Dong, B., Sha, J., Zhu, H. H., Pan, J., & Xue, W. (2022) · Cancer Letters · doi:10.1016/j.canlet.2022.215927 · Cited by 107
Hypertension and risk of prostate cancer: a systematic review and meta-analysis
Liang, Z. C., Xie, B., Li, J., Wang, X., Wang, S., Meng, S., Ji, A., Zhu, Y., Xu, X., Zheng, X., et al. (2016) · Scientific Reports · doi:10.1038/srep31358 · Cited by 102
Rectal Cancer in Asian vs. Western Countries: Why the Variation in Incidence?
Deng, Y. (2017) · Current Treatment Options in Oncology · doi:10.1007/s11864-017-0500-2 · Cited by 101
CXCR2+ MDSCs promote breast cancer progression by inducing EMT and activated T cell exhaustion
Zhu, H., Gu, Y., Xue, Y., Yuan, M., Cao, X., & Liu, Q. (2017) · Oncotarget · doi:10.18632/oncotarget.23020 · Cited by 102
Long non‐coding RNA CASC 15 regulates gastric cancer cell proliferation, migration and epithelial mesenchymal transition by targeting CDKN 1A and ZEB 1
Wu, Q., Xiang, S., Ma, J., Hui, P., Wang, T., Meng, W., Shi, M., & Wang, Y. (2018) · Molecular Oncology · doi:10.1002/1878-0261.12187 · Cited by 103
LUCAT1 promotes colorectal cancer tumorigenesis by targeting the ribosomal protein L40‐ MDM 2‐p53 pathway through binding with UBA 52
Zhou, Q., Hou, Z., Zuo, S., Xin Min, Z. H. O. U., Feng, Y., Sun, Y. J., & Yuan, X. (2019) · Cancer Science · doi:10.1111/cas.13951 · Cited by 102
Germline variation in BRCA1/2 is highly ethnic‐specific: Evidence from over 30,000 Chinese hereditary breast and ovarian cancer patients
Bhaskaran, S. P., Chandratre, K. R., Gupta, H., Zhang, L., Wang, X., Cui, J., Kim, Y. C., Sinha, S., Jiang, L., Lu, B., et al. (2019) · International Journal of Cancer · doi:10.1002/ijc.32176 · Cited by 106
Recent updates and future perspectives about amygdalin as a potential anticancer agent: A review
Shi, J., Chen, Q., Xu, M. Q., Xia, Q., Zheng, T., Teng, J., Li, M., & Fan, L. (2019) · Cancer Medicine · doi:10.1002/cam4.2197 · Cited by 102
Level of N6-Methyladenosine in Peripheral Blood RNA: A Novel Predictive Biomarker for Gastric Cancer
Ge, L., Zhang, N., Chen, Z., Song, J., Wu, Y., Li, Z., Chen, F., Wu, J., Li, D., Li, J., et al. (2020) · Clinical Chemistry · doi:10.1093/clinchem/hvz004 · Cited by 102
Development of an autophagy-related gene expression signature for prognosis prediction in prostate cancer patients
Hu, D., Li, J., Luo, S., Zhao, X., Hu, H., Zhao, G., & Tang, W. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02323-x · Cited by 102
Development and Validation of a Prognostic Nomogram for Gastric Cancer Based on DNA Methylation-Driven Differentially Expressed Genes
Bai, Y., Wei, C., Zhong, Y., Zhang, Y., Long, J., Huang, S., Xie, F., Tian, Y., Wang, X., & Zhao, H. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.41587 · Cited by 83
Incidence and mortality of laryngeal cancer in China, 2008−2012
Liu, Y., Zhao, Q., Ding, G., Zhu, Y., Li, W., & Chen, W. (2018) · Chinese Journal of Cancer Research · doi:10.21147/j.issn.1000-9604.2018.03.02 · Cited by 101
Self-citation
Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios predict chemotherapy outcomes and prognosis in patients with colorectal cancer and synchronous liver metastasis
Wu, Y., Li, C., Zhao, J., Li, Y., Liu, F., Zheng, H., Wang, Z., & Xu, Y. (2016) · World Journal of Surgical Oncology · doi:10.1186/s12957-016-1044-9 · Cited by 101
Circular RNA HIPK3 exerts oncogenic properties through suppression of miR-124 in lung cancer
Yu, H., Chen, Y., & Jiang, P. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.10.087 · Cited by 101
Risk factors for progression and prognosis of rheumatoid arthritis–associated interstitial lung disease: single center study with a large sample of Chinese population
Fu, Q., Wang, L., Li, L., Li, Y., Liu, R., & Zheng, Y. (2018) · Clinical Rheumatology · doi:10.1007/s10067-018-4382-x · Cited by 101
In silico analyses for potential key genes associated with gastric cancer
Yan, P., He, Y., Xie, K., Kong, S., & Zhao, W. (2018) · PeerJ · doi:10.7717/peerj.6092 · Cited by 101
Surgical Resection of SCLC: Prognostic Factors and the Tumor Microenvironment
Zhao, X., Kallakury, B., Chahine, J. J., Hartmann, D., Zhang, Y., Chen, Y., Zhang, H., Zhang, B., Wang, C., & Giaccone, G. (2019) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2019.01.019 · Cited by 103
Pristimerin induces apoptosis and autophagy via activation of ROS/ASK1/JNK pathway in human breast cancer in vitro and in vivo
Zhao, Q., Liu, Y., Zhong, J., Bi, Y., Liu, Y., Ren, Z., Li, X., Jia, J., Yu, M., & Yu, X. (2019) · Cell Death Discovery · doi:10.1038/s41420-019-0208-0 · Cited by 101
Self-citation
Emerging mechanisms and applications of ferroptosis in the treatment of resistant cancers
Li, B., Yang, L., Peng, X., Fan, Q., Wei, S., Yang, S., Li, X., Jin, H., Wu, B., Huang, M., et al. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110710 · Cited by 104
Stool DNA Test of Methylated Syndecan-2 for the Early Detection of Colorectal Neoplasia
Niu, F., Wen, J., Fu, X., Li, C., Zhao, R., Wu, S., Yu, H., Liu, X., Zhao, X., Liu, S., et al. (2017) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-17-0153 · Cited by 100
Anticancer drug discovery from Chinese medicinal herbs
Huang, M., Zhang, L., Ding, J., & Lu, J. (2018) · Chinese Medicine · doi:10.1186/s13020-018-0192-y · Cited by 102
First-in-class immune-modulating small molecule Icaritin in advanced hepatocellular carcinoma: preliminary results of safety, durable survival and immune biomarkers
Fan, Y., Li, S., Ding, X., Yue, J., Jiang, J., Zhao, H., Hao, R., Qiu, W., Liu, K., Li, Y., et al. (2019) · BMC Cancer · doi:10.1186/s12885-019-5471-1 · Cited by 100
miR-375-3p suppresses tumorigenesis and partially reverses chemoresistance by targeting YAP1 and SP1 in colorectal cancer cells
Xu, X., Chen, X., Xu, M., Liu, X., Pan, B., Qin, J., Xu, T., Zeng, K., Pan, Y., He, B., et al. (2019) · Aging · doi:10.18632/aging.102214 · Cited by 100
Prognostic Impact of Postoperative Lymph Node Metastases After Neoadjuvant Chemoradiotherapy for Locally Advanced Squamous Cell Carcinoma of Esophagus
Leng, X., He, W., Yang, H., Chen, Y., Zhu, C., Fang, W., Yu, Z., Mao, W., Xiang, J., Chen, Z., et al. (2019) · Annals of Surgery · doi:10.1097/sla.0000000000003727 · Cited by 100
The treatments and postoperative complications of esophageal cancer: a review
Xu, Q.-L., Li, H., Zhu, Y., & Xu, G. (2020) · Journal of Cardiothoracic Surgery · doi:10.1186/s13019-020-01202-2 · Cited by 100
A Review of the Current State of Hospice Care in China
Ling, M., Wang, X., Ma, Y., & Long, Y. (2020) · Current Oncology Reports · doi:10.1007/s11912-020-00959-y · Cited by 99
Comparison of [68 Ga]Ga-FAPI-04 and [18F]-FDG for the detection of primary and metastatic lesions in patients with gastric cancer: a bicentric retrospective study
Jiang, D., Chen, X., You, Z., Wang, H., Zhang, X., Li, X., Ren, S., Huang, Q., Hua, F., Guan, Y., et al. (2021) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-021-05441-w · Cited by 100
The role of extracellular vesicles in mediating progression, metastasis and potential treatment of hepatocellular carcinoma
Yang, N., Li, S., Li, G., Zhang, S., Tang, X., Ni, S., Jian, X.-M., Xu, C., Zhu, J., & Lu, M. (2016) · Oncotarget · doi:10.18632/oncotarget.12465 · Cited by 102
Self-citation
Multifunctional Click Hyaluronic Acid Nanogels for Targeted Protein Delivery and Effective Cancer Treatment in Vivo
Chen, J., Zou, Y., Deng, C., Meng, F., Zhang, J., & Zhong, Z. (2016) · Chemistry of Materials · doi:10.1021/acs.chemmater.6b04404 · Cited by 100
Multiple functional strategies for amplifying sensitivity of amperometric immunoassay for tumor markers: A review
Tang, Z., & Ma, Z. (2017) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2017.06.041 · Cited by 99
Characteristics of melanoma in Japan: a nationwide registry analysis 2011–2013
Tomizuka, T., Namikawa, K., & Higashi, T. (2017) · Melanoma Research · doi:10.1097/cmr.0000000000000375 · Cited by 99
miR-145-5p Suppresses Tumor Cell Migration, Invasion and Epithelial to Mesenchymal Transition by Regulating the Sp1/NF-κB Signaling Pathway in Esophageal Squamous Cell Carcinoma
Mei, L., Wang, W., Qiu, Y., Xie, X., Bai, J., & Shi, Z. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18091833 · Cited by 99
Diagnostic accuracy of dual-energy CT-based nomograms to predict lymph node metastasis in gastric cancer
Li, J., Fang, M., Wang, R., Dong, D., Tian, J., Liang, P., Liu, J., & Gao, J. (2018) · European Radiology · doi:10.1007/s00330-018-5483-2 · Cited by 99
CircRNA8924 Promotes Cervical Cancer Cell Proliferation, Migration and Invasion by Competitively Binding to MiR-518d-5p /519-5p Family and Modulating the Expression of CBX8
Liu, J., Wang, D., Long, Z., Liu, J., & Li, W. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000491716 · Cited by 98
miR-125b-5p inhibits breast cancer cell proliferation, migration and invasion by targeting KIAA1522
Li, Y., Wang, Y., Fan, H., Zhang, Z., & Li, N. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.08.172 · Cited by 99
Polydatin suppresses proliferation and metastasis of non-small cell lung cancer cells by inhibiting NLRP3 inflammasome activation via NF-κB pathway
Zou, J., Yang, Y. F., Yang, Y., & Liu, X. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.09.051 · Cited by 95
miR-29c-3p regulates DNMT3B and LATS1 methylation to inhibit tumor progression in hepatocellular carcinoma
Wu, H., Zhang, W., Wu, Z., Liu, Y., Shi, Y., Gong, J., Shen, W., & Liu, C. (2019) · Cell Death and Disease · doi:10.1038/s41419-018-1281-7 · Cited by 99
PD-L1 expression and tumor mutational burden status for prediction of response to chemotherapy and targeted therapy in non-small cell lung cancer
Chen, Y., Liu, Q., Chen, Z., Wang, Y., Yang, W., Hu, Y., Han, W., Zeng, H., Ma, H., Dai, J., et al. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1192-1 · Cited by 99
Self-citation
China National Medical Products Administration approval summary: anlotinib for the treatment of advanced non‐small cell lung cancer after two lines of chemotherapy
Zhou, M., Chen, X., Zhang, H., Xia, L., Tong, X., Zou, L., Hao, R., Pan, J., Zhao, X. Q., Chen, D., et al. (2019) · 癌症：英文版 · doi:10.1186/s40880-019-0383-7 · Cited by 100
Knowledge, practice and attitude towards HPV vaccination among college students in Beijing, China
Liu, Y., Di, N., & Xia, T. (2019) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2019.1638727 · Cited by 108
p62 promotes bladder cancer cell growth by activating KEAP1/NRF2‐dependent antioxidative response
Li, T., Jiang, D., & Wu, K. (2020) · Cancer Science · doi:10.1111/cas.14321 · Cited by 102
Deep learning with convolutional neural network in the assessment of breast cancer molecular subtypes based on US images: a multicenter retrospective study
Jiang, M., Zhang, D., Tang, S.-C., Luo, X., Chuan, Z.-R., Lv, W., Jiang, F., Ni, X., Cui, X., & Dietrich, C. F. (2020) · European Radiology · doi:10.1007/s00330-020-07544-8 · Cited by 101
Vitamin D promotes the cisplatin sensitivity of oral squamous cell carcinoma by inhibiting LCN2-modulated NF-κB pathway activation through RPS3
Huang, Z., Zhang, Y., Li, H., Zhou, Y., Zhang, Q., Chen, R., Jin, T., Hu, K., Li, S., Wang, Y., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-2177-x · Cited by 99
Self-citation
Nowcasting and forecasting global aging and cancer burden: analysis of data from the GLOBOCAN and Global Burden of Disease Study
Li, L., Shan, T., Zhang, D., & Ma, F. (2024) · Journal of the National Cancer Center · doi:10.1016/j.jncc.2024.05.002 · Cited by 99
“25 However, risk factors such as smoking, alcohol consumption, and high BMI are not the primary drivers of the increased incidence of cancer in the elderly, at least not observed signiﬁcantly diﬀerent from non-elderly cancers.”
IL-37 induces autophagy in hepatocellular carcinoma cells by inhibiting the PI3K/AKT/mTOR pathway
Li, T.-T., Zhu, D., Mou, T., Guo, Z., Pu, J., Chen, Q., Wei, X., & Wu, Z. (2017) · Molecular Immunology · doi:10.1016/j.molimm.2017.04.010 · Cited by 96
Lanatoside C inhibits cell proliferation and induces apoptosis through attenuating Wnt/β-catenin/c-Myc signaling pathway in human gastric cancer cell
Hu, Y., Yu, K., Wang, G., Zhang, D., Shi, C., Ding, Y., Hong, D., Zhang, D., He, H., Sun, L., et al. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.02.023 · Cited by 98
YAP1 contributes to NSCLC invasion and migration by promoting Slug transcription via the transcription co-factor TEAD
Yu, M., Chen, Y., Li, X., Yang, R., Zhang, L., Huangfu, L., Zheng, N., Zhao, X., Lv, L., Hong, Y., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0515-z · Cited by 102
Potential clinical application of lncRNAs in non-small cell lung cancer
Lu, T., Wang, Y., Chen, D., Liu, J., & Jiao, W. (2018) · OncoTargets and Therapy · doi:10.2147/ott.s178431 · Cited by 99
Systemic immune‐inflammation index (SII) is useful to predict survival outcomes in patients with surgically resected non‐small cell lung cancer
Guo, W., Cai, S., Zhang, F., Shao, F., Zhang, G., Zhou, Y., Zhao, L., Tan, F., Gao, S., & He, J. (2019) · Thoracic Cancer · doi:10.1111/1759-7714.12995 · Cited by 98
Self-citation
N 6 -methyladenosine mRNA methylation of PIK3CB regulates AKT signalling to promote PTEN-deficient pancreatic cancer progression
Tian, J., Zhu, Y., Rao, M., Cai, Y., Lu, Z., Zou, D., Peng, X., Ying, P., Zhang, M., Niu, S., et al. (2020) · Gut · doi:10.1136/gutjnl-2019-320179 · Cited by 97
Serum piRNA-54265 is a New Biomarker for early detection and clinical surveillance of Human Colorectal Cancer
Mai, D., Zheng, Y., Guo, H., Ding, P., Bai, R., Li, M., Ye, Y., Zhang, J., Huang, X., Liu, D., et al. (2020) · Theranostics · doi:10.7150/thno.46241 · Cited by 101
Anti-tumor activities and mechanisms of Traditional Chinese medicines formulas: A review
Fan, Y., Ma, Z., Zhao, L., Wang, W., Gao, M., Jia, X., Ouyang, H., & He, J. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110820 · Cited by 101
Self-citation
Deep learning‐based auto‐segmentation of clinical target volumes for radiotherapy treatment of cervical cancer
Ma, C., Zhou, J., Xu, X., Guo, J., Han, M., Gao, Y., Du, H., Stahl, J. N., & Maltz, J. S. (2021) · Journal of Applied Clinical Medical Physics · doi:10.1002/acm2.13470 · Cited by 98
Resveratrol inhibits hyperglycemia-driven ROS-induced invasion and migration of pancreatic cancer cells via suppression of the ERK and p38 MAPK signaling pathways
Cao, L., Chen, X., Xiao, X., Ma, Q., & Li, W. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3559 · Cited by 99
Systemic inflammation response index predicts prognosis in patients with clear cell renal cell carcinoma: a propensity score-matched analysis
Chen, Z., Wang, K., Lü, H., Xue, D., Fan, M., Zhuang, Q., Yin, S., He, X., & Xu, R. (2019) · Cancer Management and Research · doi:10.2147/cmar.s186976 · Cited by 98
Comparison of clinical outcomes of squamous cell carcinoma, adenocarcinoma, and adenosquamous carcinoma of the uterine cervix after definitive radiotherapy: a population-based analysis
Zhou, J., Wu, S., Sun, J., Li, F.-Y., Lin, H.-X., Chen, Q., & He, Z. (2016) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-016-2246-9 · Cited by 97
Value of 18F–FDG PET/CT for predicting EGFR mutations and positive ALK expression in patients with non-small cell lung cancer: a retrospective analysis of 849 Chinese patients
Lv, Z., Fan, J., Xu, J., Wu, F., Huang, Q., Guo, M., Liao, T., Liu, S., Lan, X., Liao, S., et al. (2017) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-017-3885-z · Cited by 100
Proposed Modification of the 8th Edition of the AJCC Staging System for Pancreatic Ductal Adenocarcinoma
Shi, S., Hua, J., Liang, C., Meng, Q., Liang, D., Xu, J., Ni, Q., & Yu, X. (2018) · Annals of Surgery · doi:10.1097/sla.0000000000002668 · Cited by 99
Self-citation
A Novel lncRNA, LINC00460, Affects Cell Proliferation and Apoptosis by Regulating KLF2 and CUL4A Expression in Colorectal Cancer
Lian, Y., Yan, C., Xu, H., Yang, J., Yu, Y., Zhou, J., Shi, Y., Ren, J., Ji, G., & Wang, K. (2018) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2018.06.012 · Cited by 98
Long noncoding RNA LINC00673-v4 promotes aggressiveness of lung adenocarcinoma via activating WNT/β-catenin signaling
Guan, H., Zhu, T., Wu, S., Liu, S., Liu, B., Wu, J., Cai, J., Zhu, X., Zhang, X., Zeng, M., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1900997116 · Cited by 97
The novel circCLK3/miR-320a/FoxM1 axis promotes cervical cancer progression
Hong, H., Zhu, H. H., Zhao, S., Wang, K., Zhang, N., Tian, Y., Li, Y., Wang, Y., Lv, X., Wei, T., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-2183-z · Cited by 97
Ultrasound-Based Radiomic Nomogram for Predicting Lateral Cervical Lymph Node Metastasis in Papillary Thyroid Carcinoma
Tong, Y., Li, J., Huang, Y., Zhou, J., Liu, T., Guo, Y., Yu, J., Zhou, S., Wang, Y., & Chang, C. (2020) · Academic Radiology · doi:10.1016/j.acra.2020.07.017 · Cited by 97
Molecular landscape and subtype-specific therapeutic response of nasopharyngeal carcinoma revealed by integrative pharmacogenomics
Ding, R., Chen, P., Rajendran, B. K., Lyu, X., Wang, H., Bao, J., Zeng, J., Hao, W., Sun, H., Wong, A. H., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23379-3 · Cited by 97
Inflammatory cytokine–regulated tRNA-derived fragment tRF-21 suppresses pancreatic ductal adenocarcinoma progression
Pan, L., Huang, X., Liu, Z.-X., Ye, Y., Li, R., Zhang, J., Wu, G., Bai, R., Zhuang, L., Wei, L., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci148130 · Cited by 98
Self-citation
TCF7L2 promotes anoikis resistance and metastasis of gastric cancer by transcriptionally activating PLAUR
Zhang, T., Wang, B., Su, F., Gu, B., Xiang, L., Gao, L., Zheng, P., Li, X., & Chen, H. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.69933 · Cited by 97
Lead and cadmium exposure, higher thyroid antibodies and thyroid dysfunction in Chinese women
Nie, X., Chen, Y., Chen, Y., Chen, C., Han, B., Li, Q., Zhu, C., Xia, F., Zhai, H., Wang, N., et al. (2017) · Environmental Pollution · doi:10.1016/j.envpol.2017.06.052 · Cited by 100
Noncoding RNAs in gastric cancer: Research progress and prospects
Zhang, M., & Du, X. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i29.6610 · Cited by 98
MicroRNA-346 facilitates cell growth and metastasis, and suppresses cell apoptosis in human non-small cell lung cancer by regulation of XPC/ERK/Snail/E-cadherin pathway
Sun, C., Li, S., Yuan, Z., & Li, D. (2016) · Aging · doi:10.18632/aging.101080 · Cited by 96
Retracted
Multifunctional silica nanoparticles as a promising theranostic platform for biomedical applications
Xu, Z., Ma, X., Gao, Y.-E., Hou, M., Xue, P., Li, C. M., & Kang, Y. (2017) · Materials Chemistry Frontiers · doi:10.1039/c7qm00153c · Cited by 96
PTBP1 promotes the growth of breast cancer cells through the PTEN/Akt pathway and autophagy
Wang, X., Yang, L., Fan, Y., Yu, X., Mao, X., & Jin, F. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26823 · Cited by 96
Self-citation
Down-regulation of circPVRL3 promotes the proliferation and migration of gastric cancer cells
Sun, H.-D., Xu, Z., Sun, Z., Zhu, B., Wang, Q., Zhou, J. P., Jin, H. Z., Zhao, A., Tang, W., & Cao, X. (2018) · Scientific Reports · doi:10.1038/s41598-018-27837-9 · Cited by 96
Stereotactic body radiotherapy based treatment for hepatocellular carcinoma with extensive portal vein tumor thrombosis
Shui, Y., Yu, W., Ren, X., Guo, Y., Xu, J., Ma, T., Zhang, B., Wu, J., Li, Q., Hu, Q., et al. (2018) · Radiation Oncology · doi:10.1186/s13014-018-1136-5 · Cited by 96
miR-454-3p Is an Exosomal Biomarker and Functions as a Tumor Suppressor in Glioma
Shao, N., Xue, L., Wang, R., Luo, K., Zhi, F., & Lan, Q. (2018) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-18-0725 · Cited by 96
Large-scale analysis reveals a novel risk score to predict overall survival in hepatocellular carcinoma
Zheng, Y., Liu, Y., Zhao, S., Zheng, Z., Shen, C., An, L., & Yuan, Y. (2018) · Cancer Management and Research · doi:10.2147/cmar.s181396 · Cited by 96
Bile Acid–Microbiome Interaction Promotes Gastric Carcinogenesis
Wang, S., Kuang, J., Zhang, H., Chen, W., Zheng, X., Wang, J., Huang, F., Ge, K., Li, M., Zhao, M., et al. (2022) · Advanced Science · doi:10.1002/advs.202200263 · Cited by 94
Self-citation
GTPBP4 promotes hepatocellular carcinoma progression and metastasis via the PKM2 dependent glucose metabolism
Zhou, Q., Yin, Y., Yu, M., Gao, D., Sun, J., Yang, Z., Weng, J., Chen, W., Atyah, M. M., Shen, Y., et al. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102458 · Cited by 96
Self-citation
Systemic inflammation response index (SIRI) predicts prognosis in hepatocellular carcinoma patients
Xu, L., Yu, S., Zhuang, L., Wang, P., Shen, Y., Lin, J., & Meng, Z. (2017) · Oncotarget · doi:10.18632/oncotarget.16865 · Cited by 96
Transcription factor E2F1 promotes EMT by regulating ZEB2 in small cell lung cancer
Wang, T., Chen, X., Qiao, W., Kong, L., Sun, D., & Li, Z. (2017) · BMC Cancer · doi:10.1186/s12885-017-3701-y · Cited by 95
OTUB1 promotes esophageal squamous cell carcinoma metastasis through modulating Snail stability
Zhou, H., Liu, Y., Zhu, R., Ding, F., Cao, X., Lin, D., & Liu, Z. (2018) · Oncogene · doi:10.1038/s41388-018-0224-1 · Cited by 95
RETRACTED: Hispidulin inhibits hepatocellular carcinoma growth and metastasis through AMPK and ERK signaling mediated activation of PPARγ
Han, M., Gao, H. Y., Ju, P., Gao, M., Yuan, Y., Chen, X., Liu, K.-L., Han, Y., & Han, Z. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.04.014 · Cited by 95
Retracted
Expert consensus workshop report
Ye, X., Fan, W., Wang, H., Wang, J., Wang, Z., Gu, S., Feng, W., Zhuang, Y., Liu, B., Li, X., et al. (2018) · Journal of Cancer Research and Therapeutics · doi:10.4103/jcrt.jcrt_221_18 · Cited by 96
Curcumol inhibits colorectal cancer proliferation by targeting miR-21 and modulated PTEN/PI3K/Akt pathways
Liu, H., Wang, J., Tao, Y., Li, X., Qin, J., Bai, Z., Chi, B., Yan, W., & Chen, X. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.02.049 · Cited by 95
Semi-supervised segmentation of lesion from breast ultrasound images with attentional generative adversarial network
Han, L., Huang, Y., Dou, H., Wang, S., Ahamad, S., Luo, H., Liu, Q., Fan, J., & Zhang, J. (2019) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2019.105275 · Cited by 95
Identification of prognostic immune-related genes in the tumor microenvironment of endometrial cancer
Chen, P., Yang, Y., Zhang, Y., Jiang, S., Li, X., & Wan, J. (2020) · Aging · doi:10.18632/aging.102817 · Cited by 97
Stroma-Targeting Therapy in Pancreatic Cancer: One Coin With Two Sides?
Jiang, B., Zhou, L., Lü, J., Wang, Y., Liu, C., You, L., & Guo, J. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.576399 · Cited by 104
Expert consensus on neoadjuvant immunotherapy for non-small cell lung cancer
Liang, W., Cai, K., Chen, C., Chen, H., Chen, Q., Fu, J., Hu, J., Jiang, T., Jiao, W., Li, S., et al. (2020) · Translational Lung Cancer Research · doi:10.21037/tlcr-2020-63 · Cited by 93
Self-citation

Authors: Chen, W., Zheng, R., Baade, P. D., Zhang, S., Zeng, H., Bray, F., Jemal, A., Yu, X. Q., & He, J.
Affiliations: Deputy Director, National Office for Cancer Prevention and Control National Cancer Center Beijing China
Associate Researcher, National Office for Cancer Prevention and Control National Cancer Center Beijing China
Cancer Council Queensland (AU)
Associate Professor, National Office for Cancer Prevention and Control National Cancer Center Beijing China
Centre international de recherche sur le cancer (FR)
American Cancer Society (US)
The University of Sydney (AU)
Director National Cancer Center Beijing China.
Corresponding author: Chen, Wanqing
ORCID: Chen, Wanqing
Zheng, Rongshou
Baade, Peter D.
Zhang, Siwei
Zeng, Hongmei
Bray, Freddie
Jemal, Ahmedin
Yu, Xue Qin
He, Jie
Venue: CA: A Cancer Journal for Clinicians
Publisher: Wiley
Published: 2016-01-25
Volume: 66
Issue: 2
Pages: 115-132
ISSN: 0007-9235 (ISSN-L)
1542-4863
DOI: 10.3322/caac.21338
OpenAlex: W2272984102
Cited by: 17,038
References: 85
Citations by year: 2026: 142 · 2025: 461 · 2024: 1006 · 2023: 1271 · 2022: 1900 · 2021: 2470 · 2020: 2710 · 2019: 2630 · 2018: 2296 · 2017: 1648 · 2016: 486
FWCI: 1269.33
Type: journal article
Language: en
Open access: gold
doi.org
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor)
Locations: CA A Cancer Journal for Clinicians (publishedVersion)
PubMed (publishedVersion)
Griffith Research Online (submittedVersion, other-oa)
The Sydney eScholarship Repository (The University of Sydney) (submittedVersion)
Funders: National Health and Family Planning Commission of China
Ministry of Science and Technology (2014FY121100)
Topics: Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
Health Sciences › Medicine › Oncology › Colorectal Cancer Screening and Detection
Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Economic and Financial Impacts of Cancer
Keywords: cancer incidence, cancer mortality, cancer burden estimation, lung cancer, gastric cancer, esophageal cancer, liver cancer, urban-rural differences, cancer incidence trends, population-based cancer registry, cancer prevention, China
MeSH terms: Adult, Aged, China, Esophageal Neoplasms, Female, Humans, Liver Neoplasms, Lung Neoplasms, Male, Middle Aged, Neoplasms, Risk Factors, Rural Population, Stomach Neoplasms, Urban Population, Incidence, Prevalence, Survival Rate, Sex Distribution

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Cancer statistics in China, 2015

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks